Your browser doesn't support javascript.
loading
Genome-wide germline correlates of the epigenetic landscape of prostate cancer.
Houlahan, Kathleen E; Shiah, Yu-Jia; Gusev, Alexander; Yuan, Jiapei; Ahmed, Musaddeque; Shetty, Anamay; Ramanand, Susmita G; Yao, Cindy Q; Bell, Connor; O'Connor, Edward; Huang, Vincent; Fraser, Michael; Heisler, Lawrence E; Livingstone, Julie; Yamaguchi, Takafumi N; Rouette, Alexandre; Foucal, Adrien; Espiritu, Shadrielle Melijah G; Sinha, Ankit; Sam, Michelle; Timms, Lee; Johns, Jeremy; Wong, Ada; Murison, Alex; Orain, Michèle; Picard, Valérie; Hovington, Hélène; Bergeron, Alain; Lacombe, Louis; Lupien, Mathieu; Fradet, Yves; Têtu, Bernard; McPherson, John D; Pasaniuc, Bogdan; Kislinger, Thomas; Chua, Melvin L K; Pomerantz, Mark M; van der Kwast, Theodorus; Freedman, Matthew L; Mani, Ram S; He, Housheng H; Bristow, Robert G; Boutros, Paul C.
Afiliação
  • Houlahan KE; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Shiah YJ; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Gusev A; Vector Institute, Toronto, Ontario, Canada.
  • Yuan J; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Ahmed M; Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Shetty A; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Ramanand SG; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Yao CQ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Bell C; Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • O'Connor E; University of Cambridge, Cambridge, UK.
  • Huang V; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
  • Fraser M; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Heisler LE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Livingstone J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Yamaguchi TN; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Rouette A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Foucal A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Espiritu SMG; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Sinha A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Sam M; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Timms L; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Johns J; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Wong A; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Murison A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Orain M; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Picard V; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Hovington H; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Bergeron A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Lacombe L; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Lupien M; Department of Pathology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
  • Fradet Y; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
  • Têtu B; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
  • McPherson JD; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
  • Pasaniuc B; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
  • Kislinger T; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Chua MLK; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Pomerantz MM; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • van der Kwast T; Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
  • Freedman ML; Department of Pathology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
  • Mani RS; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • He HH; Department of Computational Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Bristow RG; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Boutros PC; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA.
Nat Med ; 25(10): 1615-1626, 2019 10.
Article em En | MEDLINE | ID: mdl-31591588
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Mutação em Linhagem Germinativa / Metilação de DNA / Epigenoma Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Mutação em Linhagem Germinativa / Metilação de DNA / Epigenoma Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá